Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure

Rajiv Agarwal, Ricardo Correa-Rotter, Sankar D. Navaneethan, Hiddo J.L. Heerspink, Matthew R. Weir, Janet B. McGill, Amy K. Mottl, Masaomi Nangaku, Julio Rosenstock, Peter Rossing, Muthiah Vaduganathan, Charlie Scott, Li Li, Meike Brinker, Csaba P. Kovesdy, Jennifer B. Green, Johannes F.E. Mann

Open source

DOI: 10.1161/hypertensionaha.126.27036
Published: 2026-09
Container: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/hypertensionaha.126.27036,
  title = {Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure},
  author = {Rajiv Agarwal and Ricardo Correa-Rotter and Sankar D. Navaneethan and Hiddo J.L. Heerspink and Matthew R. Weir and Janet B. McGill and Amy K. Mottl and Masaomi Nangaku and Julio Rosenstock and Peter Rossing and Muthiah Vaduganathan and Charlie Scott and Li Li and Meike Brinker and Csaba P. Kovesdy and Jennifer B. Green and Johannes F.E. Mann},
  year = {2026},
  journal = {Hypertension},
  doi = {10.1161/hypertensionaha.126.27036},
  url = {https://doi.org/10.1161/hypertensionaha.126.27036}
}

RIS

TY  - JOUR
TI  - Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure
AU  - Rajiv Agarwal
AU  - Ricardo Correa-Rotter
AU  - Sankar D. Navaneethan
AU  - Hiddo J.L. Heerspink
AU  - Matthew R. Weir
AU  - Janet B. McGill
AU  - Amy K. Mottl
AU  - Masaomi Nangaku
AU  - Julio Rosenstock
AU  - Peter Rossing
AU  - Muthiah Vaduganathan
AU  - Charlie Scott
AU  - Li Li
AU  - Meike Brinker
AU  - Csaba P. Kovesdy
AU  - Jennifer B. Green
AU  - Johannes F.E. Mann
PY  - 2026
JO  - Hypertension
DO  - 10.1161/hypertensionaha.126.27036
UR  - https://doi.org/10.1161/hypertensionaha.126.27036
ER  -

APA

Agarwal, R., Correa-Rotter, R., Navaneethan, S. D., Heerspink, H. J., Weir, M. R., McGill, J. B., Mottl, A. K., Nangaku, M., Rosenstock, J., Rossing, P., Vaduganathan, M., Scott, C., Li, L., Brinker, M., Kovesdy, C. P., Green, J. B., & Mann, J. F. (2026). Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure. Hypertension. https://doi.org/10.1161/hypertensionaha.126.27036

Source records

crossref · retrieved 2026-09-27T00:44:53.197Z